BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30782608)

  • 21. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway.
    Chen SQ; Ding LN; Zeng NX; Liu HM; Zheng SH; Xu JW; Li RM
    Biomed Pharmacother; 2019 Jul; 115():108930. PubMed ID: 31055234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient activation of AMPK preceding left ventricular pressure overload reduces adverse remodeling and preserves left ventricular function.
    Nam DH; Kim E; Benham A; Park HK; Soibam B; Taffet GE; Kaelber JT; Suh JH; Taegtmeyer H; Entman ML; Reineke EL
    FASEB J; 2019 Jan; 33(1):711-721. PubMed ID: 30024790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irisin protects against doxorubicin-induced cardiotoxicity by improving AMPK-Nrf2 dependent mitochondrial fusion and strengthening endogenous anti-oxidant defense mechanisms.
    Zhuo C; Xin J; Huang W; Zhang D; Yan X; Li R; Li H; Lan J; Lin L; Li L; Wang X; Liu L; Wang Y; Li X; Mao Y; Chen H; Wu S; Yang X; Jiang W
    Toxicology; 2023 Aug; 494():153597. PubMed ID: 37499777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance.
    Zerlotin R; Fornaro M; Errede M; Pignataro P; Suriano C; Ruggieri M; Colucci S; Iannone F; Grano M; Colaianni G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irisin ameliorates angiotensin II-induced cardiomyocyte apoptosis through autophagy.
    Li R; Wang X; Wu S; Wu Y; Chen H; Xin J; Li H; Lan J; Xue K; Li X; Zhuo C; He J; Tang CS; Jiang W
    J Cell Physiol; 2019 Aug; 234(10):17578-17588. PubMed ID: 30793300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
    Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
    J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
    Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
    Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway.
    Hu L; Wang Z; Li H; Wei J; Tang F; Wang Q; Wang J; Zhang X; Zhang Q
    Biochem Biophys Res Commun; 2022 Feb; 593():65-72. PubMed ID: 35063771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
    Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
    Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic Acid Increases Fatty Acid Oxidation and Irisin Expression in Skeletal Muscle Cells and Impacts Irisin In Vivo.
    Amengual J; García-Carrizo FJ; Arreguín A; Mušinović H; Granados N; Palou A; Bonet ML; Ribot J
    Cell Physiol Biochem; 2018; 46(1):187-202. PubMed ID: 29587291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
    Liu X; Li B; Wang S; Zhang E; Schultz M; Touma M; Monteiro Da Rocha A; Evans SM; Eichmann A; Herron T; Chen R; Xiong D; Jaworski A; Weiss S; Si MS
    Circ Res; 2024 Mar; 134(7):913-930. PubMed ID: 38414132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calhex₂₃₁ Ameliorates Cardiac Hypertrophy by Inhibiting Cellular Autophagy in Vivo and in Vitro.
    Liu L; Wang C; Sun D; Jiang S; Li H; Zhang W; Zhao Y; Xi Y; Shi S; Lu F; Tian Y; Xu C; Wang L
    Cell Physiol Biochem; 2015; 36(4):1597-612. PubMed ID: 26159880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway.
    Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W
    Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.